Literature DB >> 2932415

Adventure, Etc.--a health-promotion program for chronically ill and disabled youth.

M Kessell, M D Resnick, R W Blum.   

Abstract

Adolescents with a chronic illness or physical disability have a more difficult time separating from parents, achieving a sense of mastery, developing social skills among peers, and achieving a positive body-image than do able-bodied adolescents. To promote attainment of these developmental tasks, Adventure, Etc. was created as a wilderness/urban Outward Bound experience for chronically ill, physically disabled, and able-bodied teens. Pre- and posttesting and interviewing assessed locus of control, self-image, family environment, and family dynamics. Over a two-year period, 37 teens completed the program and were tested; 23 were chronically ill or disabled. The chronically ill/disabled group showed a significant increase in internal locus of control. No change was found in the able-bodied group. Both the able-bodied and the disabled/chronically ill groups showed a significant improvement in body image. Reported family conflict declined, as did family recreational involvement, while individual recreational activities among these adolescents increased. Based on these results, new follow-up activities for the parents and adolescents were initiated to further the gains of program participants.

Entities:  

Mesh:

Year:  1985        PMID: 2932415     DOI: 10.1016/s0197-0070(85)80048-6

Source DB:  PubMed          Journal:  J Adolesc Health Care        ISSN: 0197-0070


  2 in total

Review 1.  Camping programs for children with cancer and their families.

Authors:  Alexandra L C Martiniuk
Journal:  Support Care Cancer       Date:  2003-10-01       Impact factor: 3.603

Review 2.  A scoping review to map the concept, content, and outcome of wilderness programs for childhood cancer survivors.

Authors:  Mats Jong; E Anne Lown; Winnie Schats; Michelle L Mills; Heather R Otto; Leiv E Gabrielsen; Miek C Jong
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.